KD025-208: A Phase 2a Study of KD025 for Patients With Chronic Graft Versus Host Disease (cGVHD)-Pharmacodynamics and Updated Results

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [41] Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
    Koshy, Anita G.
    Kim, Haesook T.
    Liegel, Jessica
    Arnason, Jon
    Ho, Vincent T.
    Antin, Joseph H.
    Joyce, Robin
    Cutler, Corey
    Gooptu, Mahasweta
    Nikiforow, Sarah
    Logan, Emma K.
    Elavalakanar, Pavania
    Narcis, Michele
    Stroopinsky, Dina
    Avigan, Zachary M.
    Boussi, Leora
    Stephenson, Susan
    El Banna, Hassan
    Bindal, Poorva
    Cheloni, Giulia
    Avigan, David E.
    Soiffer, Robert J.
    Rosenblatt, Jacalyn
    BLOOD, 2023, 141 (24) : 2932 - 2943
  • [42] Pharmacokinetic Analysis of Baricitinib in Phase 1-2 Study for Treatment Refractory Chronic Graft-Versus-Host Disease
    Zimmerman, Sara M.
    Holtzman, Noa G.
    Im, Annie P.
    Ostojic, Alen
    Magone, M. Teresa
    Cowen, Edward W.
    Mays, Jacqueline W.
    Figg, William Douglas, Sr.
    Pavleti, Steven Z.
    Peer, Cody
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 373 - 374
  • [43] Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study
    Miklos, David Bernard
    Abu Zaid, Mohammad
    Cooney, Julian P.
    Albring, Joern C.
    Flowers, Mary
    Skarbnik, Alan P.
    Yakoub-Agha, Ibrahim
    Ko, Bor-Sheng
    Bruno, Benedetto
    Waller, Edmund K.
    Yared, Jean
    Sohn, Sang Kyun
    Bulabois, Claude-Eric
    Teshima, Takanori
    Jacobsohn, David
    Greinix, Hildegard
    Mokatrin, Ahmad
    Lee, Yihua
    Wahlstrom, Justin T.
    Styles, Lori
    Socie, Gerard
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) : 1876 - +
  • [44] Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a multicenter study of patients with acute leukemia undergoing allogeneic PBSCT
    Delia, M.
    Carluccio, P.
    Gagliardi, V. P.
    Mestice, A.
    Chiusolo, P.
    Arpinati, M.
    Milone, G. A.
    Martino, M.
    Mazza, P.
    Ingrosso, C.
    Vacca, A.
    Saporiti, G.
    Zallio, F.
    Attolico, I.
    Albano, F.
    Musto, P.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 42 - 43
  • [45] PHASE 1 TRIAL INVESTIGATING THE SAFETY AND TOLERABILITY OF LEFLUNOMIDE IN PATIENTS WITH STEROID-DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (ALLOHCT)
    Salhotra, Amandeep
    Yang, Dongyun
    Mokhtari, Sally
    Modi, Badri
    Al-Malki, Monzr
    Ali, Haris
    Amannam, Idoroenyi
    Karras, Nicole
    Sandhu, Karamjeet
    Aribi, Ahmed
    Otoukesh, Salman
    Artz, Andrew
    Marcucci, Guido
    Forman, Stephen
    Smith, Eileen
    Zhang, De-Fu
    Rosen, Steven
    Nakamura, Ryotaro
    BONE MARROW TRANSPLANTATION, 2024, 59 : 296 - 297
  • [46] Itacitinib and Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease: Phase 1/2 Results from Gravitas-309
    Im, Annie
    Wolff, Daniel
    Cutler, Corey
    Zeiser, Robert
    Shah, Nirav N.
    Tan, Ming Tony
    Sanz, Jaime
    Ali, Haris
    Milone, Giuseppe
    LaW, Arjun D.
    Russo, Domenico
    Wagner, Eva-Maria
    Ivanova, Olga
    Hou, Kevin
    Bleam, Maureen
    Morariu-Zamfir, Rodica
    Pavletic, Steven Z.
    BLOOD, 2022, 140 : 1870 - 1871
  • [47] Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study
    Kitko, Carrie L.
    Arora, Mukta
    DeFilipp, Zachariah
    Abu Zaid, Mohammad
    Di Stasi, Antonio
    Radojcic, Vedran
    Betts, Courtney B.
    Coussens, Lisa M.
    Meyers, Michael L.
    Qamoos, Hope
    Ordentlich, Peter
    Kumar, Vinit
    Quaranto, Christine
    Schmitt, Aaron
    Gu, Yu
    Blazar, Bruce R.
    Wang, Trent P.
    Salhotra, Amandeep
    Pusic, Iskra
    Jagasia, Madan
    Lee, Stephanie J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) : 1864 - +
  • [48] A Prospective Multicenter Phase II Trial of Pentostatin in Adult Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease (cGvHD): A Cancer and Leukemia Group B/Eastern Cooperative Oncology Group Study.
    Farag, Sherif
    Owzar, Kouros
    Hars, Vera
    Lazarus, Hillard M.
    Stadtmauer, Edward A.
    Devine, Steven M.
    van Besien, Koen
    Linker, Charles
    BLOOD, 2009, 114 (22) : 882 - 882
  • [49] An Open-labeled, Multicenter Phase II Study of Tamibarotene in Patients with Steroid-refractory Chronic Graft-versus-Host Disease
    Maeda, Yoshinobu
    Nishimori, Hisakazu
    Inamoto, Yoshihiro
    Nakamae, Hirohisa
    Sawa, Masashi
    Mori, Yasuo
    Ohashi, Kazuteru
    Fujiwara, Shin-Ichiro
    Tanimoto, Mitsune
    ACTA MEDICA OKAYAMA, 2016, 70 (05) : 409 - 412
  • [50] Sustained Immunogenic and Clinical Effects of Low-Dose Interleukin-2 Therapy with an Intermittent Maintenance Method for Refractory Chronic Graft-Versus-Host Disease: Results of Phase1/2a LDIL2-01 Study
    Meguri, Yusuke
    Ohashi, Kazuteru
    Inamoto, Yoshihiro
    Iyama, Satoshi
    Ohwada, Chikako
    Murata, Makoto
    Satake, Atsushi
    Mori, Yasuo
    Nakase, Koichi
    Yoshida, Chikamasa
    Doki, Noriko
    Najima, Yuho
    Nishida, Tetsuya
    Maeda, Yoshinobu
    Matsuoka, Ken-ichi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S175 - S175
12345